Table 2.

Nasal cytology and immunohistochemistry findings, subdivided by low, medium and high CCG.

	Entire population	Patients with low CCG, N = 10 (25.6%)	Patients with moderate CCG, N = 13 (33.3%)	Patients with high CCG, N = 16 (41.0%)	P value
Nasal cytology findings
Patients with eosinophils, %	46.2	100.0	46.2	12.5	< 0.0001
Patients with mast cells, %	5.1	0.0	7.7	6.3	0.685
Patients with eosinophils + mast cells, %	48.7	0.0	46.2	81.3	< 0.0001
Immunohistochemistry findings
Eosinophilis count, median (IQ 25–75)	22 (7–45)	15 (4–42)	17 (4.5–38.5)	30 (13.5–56.5)	0.234
Mast cells count, median (IQ 25–75)	11 (3–20)	9 (8–11)	6 (2.5–10.5)	17.5 (11–33)	0.018
Lamina propria mast cells count, median (IQ 25–75)	7 (3–16)	9 (3–11)	4.5 (2–8)	7 (4.5–18)	0.202
Intraepithelial mast cells count, median (IQ 25–75)	0 (4–9)	0 (0–5)	1 (0–4)	9 (3.5–22)	< 0.0001
Mast cells presence, %	97.4	90.0	100.0	100.0	0.226
Lamina propria mast cells presence, %	97.4	90.0	100.0	100.0	0.226
Intraepithelial mast cells presence, %	64.1	30.0	46.2	100.0	< 0.0001
Intraepithelial mast cells ≥ lamina propria mast cells, %	25.6	20.0	7.7	43.8	0.077

Significant are in value [bold].